Hong Ju - Shandong Weigao Executive
| SHWGFDelisted Stock | USD 0.96 0.00 0.00% |
Executive
Mr. Ju Hong Feng is ViceGeneral Manager of the Production and Supply Chain of Shandong Weigao Group Medical Polymer Co Ltd. Mr. Ju graduated from Shandong University and obtained a MBA degree from Northwestern University in 2014. Mr. Ju joined the Company in June 2002 and acted as the manager of financial and accounts department of the Company. He acted as the chief financial officer of the Company since January 2009, the chief operating officer of Weigao Holding Company Limited and the general manager of the pharmaceutical distribution business division since February 2014 and the vicegeneral manager of the production and supply chain of the Company since January 2016. Mr. Ju has over 10 years of valuable experiences in finance and operating in the medical device industry in China. since 2016.
| Age | 48 |
| Tenure | 8 years |
| Phone | 86 63 1562 1999 |
| Web | https://www.weigaogroup.com |
Shandong Weigao Management Efficiency
The company has return on total asset (ROA) of 0.0604 % which means that it generated a profit of $0.0604 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1276 %, meaning that it generated $0.1276 on every $100 dollars invested by stockholders. Shandong Weigao's management efficiency ratios could be used to measure how well Shandong Weigao manages its routine affairs as well as how well it operates its assets and liabilities.Shandong Weigao Group has accumulated 3.46 B in total debt with debt to equity ratio (D/E) of 0.2, which may suggest the company is not taking enough advantage from borrowing. Shandong Weigao Group has a current ratio of 2.93, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Shandong Weigao until it has trouble settling it off, either with new capital or with free cash flow. So, Shandong Weigao's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Shandong Weigao Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Shandong to invest in growth at high rates of return. When we think about Shandong Weigao's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Piero Novello | Baxter International | N/A | |
| David Rosenbloom | Baxter International | 64 | |
| Scott Centea | AngioDynamics | 45 | |
| Michele Polinsky | West Pharmaceutical Services | N/A | |
| Kaushik Ghoshal | ResMed Inc | 56 | |
| Todd Friedman | ResMed Inc | N/A | |
| Carlos MD | ResMed Inc | 58 | |
| Dawn Haake | ResMed Inc | N/A | |
| Gerard Greco | Baxter International | 62 | |
| Charles Patel | Baxter International | 54 | |
| Kathy DePadua | West Pharmaceutical Services | N/A | |
| Saleem Cheeks | AngioDynamics | N/A | |
| Hemanth Reddy | ResMed Inc | N/A | |
| Ginny Blocki | Embecta Corp | N/A | |
| Clay Fradd | ICU Medical | N/A | |
| Laurie Miller | Haemonetics | 50 | |
| Jean Casner | Embecta Corp | 66 | |
| Tom Blount | Embecta Corp | 50 | |
| Christian Voigtlander | ICU Medical | 56 | |
| Marna BronfenMoore | AngioDynamics | 57 | |
| Talvis Love | Baxter International | 56 | |
Management Performance
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0604 |
Shandong Weigao Group Leadership Team
Elected by the shareholders, the Shandong Weigao's board of directors comprises two types of representatives: Shandong Weigao inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shandong. The board's role is to monitor Shandong Weigao's management team and ensure that shareholders' interests are well served. Shandong Weigao's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shandong Weigao's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Junqiang Lu, Ex Director | ||
| Shili Ni, Ex Director | ||
| Miu Wong, Company Secretary | ||
| Hong Ju, Vice-General Manager of the Production and Supply Chain | ||
| Rinan Cong, CEO Director | ||
| Xue Wu, Chief Officer | ||
| Jing Long, Vice-General Manager of Marketing Management |
Shandong Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Shandong Weigao a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0604 | |||
| Profit Margin | 0.18 % | |||
| Operating Margin | 0.22 % | |||
| Current Valuation | 6.24 B | |||
| Shares Outstanding | 4.52 B | |||
| Shares Owned By Insiders | 46.39 % | |||
| Shares Owned By Institutions | 24.74 % | |||
| Price To Earning | 20.29 X | |||
| Price To Book | 2.20 X |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Shandong Pink Sheet
If you are still planning to invest in Shandong Weigao Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Shandong Weigao's history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |